Twyce GmbH
twyce-therapeutics.com
Oncology Therapeutics
Cell & Gene Therapy
Biologics & Biosimilars
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Helmholtz
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Next-generation CAR T-cell therapies engineered to disrupt the tumor microenvironment OUR MISSION CARTemis Therapeutics is a clinical-stage…
Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies…
SirnaMed is committed to developing innovative therapies that directly target the cause of cancer development, progression and treatment…
The Next Generation in. OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid…
Stratosvir. Revolutionizing cancer treatment through viral immunotherapy.
Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery…
Overview
Game changing cancer immunotherapy We develop unique, T cell-recruiting antibody-therapy for patients suffering from solid tumors where current treatment options fail. At TWYCE, our physician scientists develop combinatorial, bispecific antibody therapies from bench to clinical practice.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
HelmholtzVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Tübingen
Germany
HQ